Resistance of HIV-1 reverse transcriptase against [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5“-(4”-amino-1“,2”- oxathiole-2“,2”-dioxide)] (TSAO) derivatives is determined by the mutation Glu138–>Lys on the p51 subunit.
Open Access
- 1 October 1994
- journal article
- Published by Elsevier
- Vol. 269 (41) , 25255-25258
- https://doi.org/10.1016/s0021-9258(18)47240-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Sensitivity of (138 Glu → Lys) Mutated Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase (RT) to HIV-1-Specific RT InhibitorsBiochemical and Biophysical Research Communications, 1994
- HIV-1 reverse transcriptase: Polymerization properties of the p51 homodimer compared to the p66/p51 heterodimerBiochemistry, 1993
- Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an InhibitorScience, 1992
- Structure of HIV-1 reverse transcriptase/DNA complex at 7 Å resolution showing active site locationsNature, 1992
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- Characterization of the human immunodeficiency virus type-1 reverse transcriptase enzyme produced in yeastBiochemical and Biophysical Research Communications, 1990
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990
- Enzymatically Active Forms of Reverse Transcriptase of the Human Immunodeficiency VirusAIDS Research and Human Retroviruses, 1988
- Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAVScience, 1986
- Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectorsGene, 1985